National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Hydrocortisone modified-release hard capsules (Efmody®). HTA ID: 21042

Hydrocortisone modified-release hard capsules are indicated for the treatment of congenital adrenal hyperplasia in adolescents aged 12 years and over and adults.


NCPE Assessment Process Complete
Rapid review commissioned 08/09/2021
Rapid review completed 04/11/2021
Rapid Review outcome A full HTA is not recommended. The NCPE recommends that Efmody® not be considered for reimbursement at the submitted price*.


*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.